Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. S. (Steven) de Jong

Publicaties

Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

NOTCH signaling limits the response of Low Grade Serous Ovarian Cancers to MEK inhibition

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities

Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts (Nature Genetics, (2021), 53, 1, (86-99), 10.1038/s41588-020-00750-6)

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines

Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

Lees meer